Related Experiment Video
Updated: Mar 20, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
MT1-MMP Inhibits the Activity of Bst-2 via Their Cytoplasmic Domains Dependent Interaction
Long Fan1, Li Liu2, Cuicui Zhu3
1Jiangsu Province Key Laboratory for Molecular and Medicine Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China. fl891116@163.com.
Abstract:
Bst-2 (bone marrow stromal cell antigen 2) is a type II membrane protein, and it acts as a tetherin to inhibit virion releasing from infectious cells. Membrane type-1 matrix metalloproteinase (MT1-MMP) is a protease. It plays a pivotal role in cellular growth and migration by activating proMMP-2 into active MMP2. Our results here elaborate that MT1-MMP inhibits the tetherin activity of Bst-2 by interacting with Bst-2, and the cytoplasmic domains of both Bst-2 and MT1-MMP play critical roles within this interaction. Based on our experimental data, the assays for virion release and co-immunoprecipitation have clearly demonstrated that the activity of Bst-2 is markedly inhibited by MT1-MMP via their interaction; and both the N-terminal domain of Bst-2 and the C-terminal domain of MT1-MMP are important in the interaction. Immunostaining and Confocal Microscopy assay shows that MT1-MMP interacts with Bst-2 to form granular particles trafficking into cytoplasm from membrane and, finally, results in Bst-2 and MT1-MMP both being inhibited. In addition, mutant experiments elucidate that the N-terminal domain of Bst-2 is not only important in relating to the activity of Bst-2 itself, but is important for inhibiting the MT1-MMP/proMMP2/MMP2 pathway. These findings suggest that MT1-MMP is a novel inhibitor of Bst-2 in MT1-MMP expressed cell lines and also indicate that both the N-terminal domain of Bst-2 and the C-terminal domain of MT1-MMP are crucial in down-regulation.
Insights
Membrane type-1 matrix metalloproteinase (MT1-MMP) inhibits bone marrow stromal cell antigen 2 (Bst-2) tetherin activity. This interaction, involving specific protein domains, leads to the downregulation of both Bst-2 and MT1-MMP.
Area of Science:
- Virology
- Cell Biology
- Biochemistry
Background:
- Bone marrow stromal cell antigen 2 (Bst-2) is a type II membrane protein functioning as a tetherin to restrict virion release from infected cells.
- Membrane type-1 matrix metalloproteinase (MT1-MMP) is a protease crucial for cell growth and migration, notably by activating proMMP-2 to MMP2.
Purpose of the Study:
- To investigate the inhibitory effect of MT1-MMP on Bst-2 tetherin activity.
- To elucidate the molecular mechanisms and specific domains involved in the interaction between Bst-2 and MT1-MMP.
Main Methods:
- Virion release assays
- Co-immunoprecipitation assays
- Immunostaining and Confocal Microscopy
- Mutant experiments
Main Results:
- MT1-MMP was demonstrated to inhibit Bst-2 tetherin activity through direct interaction.
- The cytoplasmic domains of Bst-2 and MT1-MMP, specifically the N-terminal domain of Bst-2 and the C-terminal domain of MT1-MMP, are critical for this interaction.
- MT1-MMP and Bst-2 form granular particles that traffic into the cytoplasm, leading to the inhibition of both proteins.
- Mutant experiments revealed the N-terminal domain of Bst-2 is also important for inhibiting the MT1-MMP/proMMP2/MMP2 pathway.
Conclusions:
- MT1-MMP acts as a novel inhibitor of Bst-2 in cells expressing MT1-MMP.
- The N-terminal domain of Bst-2 and the C-terminal domain of MT1-MMP are crucial for the downregulation of Bst-2 activity by MT1-MMP.
Related Concept Videos
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Role of Matrix Metalloproteases in Degradation of ECM
PI3K/mTOR/AKT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

